Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Vanguard

Vanguard Value Index Fund Institutional Shares (VIVIX)

Ticker VIVIX · Index fund · · Holdings as of Jun 30, 2026

Expense ratio
0.03%$3/yr per $10k
5-yr return
+12.6%annualized
1-yr return
+15.3%as of Dec 2025
Net assets
$254.5Ball share classes
Holdings
326

Bottom line

Is VIVIX a good fund? The bottom line

VIVIX is the Institutional share class of Vanguard Value Index Fund, an index large value mutual fund from Vanguard.

It charges 0.03% — about $3 a year on every $10,000 invested, cheaper than 98% of large value funds we track.

It returned +15.3% over one year, +12.6% a year over five years, +11.7% a year over ten (as of Dec 31, 2025, per its prospectus).

With $254 billion in net assets and 326 holdings, its largest position is Micron Technology Inc (4.9%) and the top 10 make up 23.6% of the portfolio.

What stands out

  • Low cost: cheaper than 98% of large value peers
  • 5-year return beat 75% of category peers
  • Broadly diversified (326 holdings)
  • No front-end sales load
  • Large and established ($254 billion)

Updated Nov 19, 2026

What VIVIX invests in

Vanguard Value ETF, an exchange-traded share class of Vanguard Value Index Fund (the Fund), seeks to track the performance of a benchmark index that measures the investment return of large-capitalization value stocks.

The Fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index (the Target Index), a broadly diversified index made up of the value stocks of large U.S. companies, as determined by the index provider. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks that make up the Target Index. The Fund attempts to replicate the Target Index by investing all, or substantially all, of its assets in the stocks that make up the Target Index, holding each stock in approximately the same proportion as its weighting in the Target Index.

From the fund's prospectus (filed Apr 28, 2026).

VIVIX performance

Fund calendar-year total returns, 2018–2025 2018: −5.4%; 2019: +25.8%; 2020: +2.3%; 2021: +26.5%; 2022: −2.1%; 2023: +9.3%; 2024: +16.0%; 2025: +15.3% −5% 2018 +26% 2019 +2% 2020 +26% 2021 −2% 2022 +9% 2023 +16% 2024 +15% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
VIVIX+15.3%+12.6%+11.7%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full VIVIX performance history →

What VIVIX costs

On a $10,000 investment, VIVIX's 0.03% expense ratio costs about $3 a year. The prospectus estimates $39 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full VIVIX fee table →

VIVIX top 10 holdings

#Holding% of fund
1Micron Technology Inc4.87%
2JPMorgan Chase & Co3.06%
3Berkshire Hathaway Inc2.95%
4Johnson & Johnson2.29%
5Exxon Mobil Corp2.12%
6Walmart Inc1.86%
7Caterpillar Inc1.83%
8AbbVie Inc1.66%
9Cisco Systems Inc1.56%
10UnitedHealth Group Inc1.41%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 23.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to VIVIX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SchwabSCHV Schwab U.S. Large-Cap Value ETF0.04%81% Compare
iSharesIWD iShares Russell 1000 Value ETF0.18%59% Compare
FidelityFELV Fidelity Enhanced Large Cap Value ETF0.18%51% Compare
DimensionalDFUV Dimensional US Marketwide Value ETF0.21%55% Compare

More funds like VIVIX →

VIVIX FAQ

What is the expense ratio of VIVIX?
VIVIX's expense ratio is 0.03%, which works out to about $3 a year for every $10,000 invested. The prospectus estimates total costs of $39 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VIVIX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 98% of large value peers; 5-year return beat 75% of category peers; broadly diversified (326 holdings); no front-end sales load; large and established ($254 billion). This is general information, not personalized advice.
What does VIVIX hold?
VIVIX's largest holdings are Micron Technology Inc (4.9%), JPMorgan Chase & Co (3.1%), Berkshire Hathaway Inc (2.9%), Johnson & Johnson (2.3%), Exxon Mobil Corp (2.1%). It holds 326 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is VIVIX's 5-year return?
VIVIX returned +12.6% a year over the five years ending Dec 31, 2025, and +11.7% a year over ten years. Past performance does not guarantee future results.
Does VIVIX have a sales load?
No. VIVIX has no front-end sales charge.
Is there an ETF version of VIVIX?
Yes — VTV is the ETF share class of the same fund, so it holds the same portfolio. Its expense ratio is 0.03%.
Who manages VIVIX?
VIVIX is offered by Vanguard through Vanguard Index Funds.